Prelude Therapeutics Inc

$ 2.45

9.87%

26 Dec - close price

  • Market Cap 154,020,000 USD
  • Current Price $ 2.45
  • High / Low $ 2.48 / 2.21
  • Stock P/E N/A
  • Book Value 0.77
  • EPS -1.47
  • Next Earning Report 2026-03-18
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA -0.52 %
  • ROE -1.04 %
  • 52 Week High 4.22
  • 52 Week Low 0.61

About

Prelude Therapeutics Inc. is a clinical-stage oncology company headquartered in Wilmington, Delaware, dedicated to innovating precision small molecule therapies that directly target key oncogenic drivers. The company is advancing a promising pipeline bolstered by its proprietary drug discovery platform, which focuses on delivering novel treatment options for patients afflicted with advanced cancers. With an unwavering commitment to precision medicine and a strategic vision for addressing underserved oncology needs, Prelude Therapeutics represents a compelling investment opportunity for institutional investors seeking to capitalize on growth in the biotech sector.

Analyst Target Price

$4.00

Quarterly Earnings

Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
Reported Date 2025-11-122025-08-142025-05-052025-02-132024-10-302024-08-122024-05-072024-02-152023-11-012023-08-032023-05-082023-03-15
Reported EPS -0.26-0.41-0.42-0.37-0.43-0.46-0.42-0.46-0.45-0.54-0.58-0.6
Estimated EPS -0.3697-0.48-0.48-0.4673-0.47-0.43-0.48-0.49-0.58-0.63-0.68-0.63
Surprise 0.10970.070.060.09730.04-0.030.060.030.130.090.10.03
Surprise Percentage 29.6727%14.5833%12.5%20.8217%8.5106%-6.9767%12.5%6.1224%22.4138%14.2857%14.7059%4.7619%

Next Quarterly Earnings

Dec 2025
Reported Date 2026-03-18
Fiscal Date Ending 2025-12-31
Estimated EPS -0.13
Currency USD

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi